Milnacipran treatment and potential biomarkers in depressed patients following an initial SSRI treatment failure: a prospective, open-label, 24-week study.
about
Milnacipran treatment and potential biomarkers in depressed patients following an initial SSRI treatment failure: a prospective, open-label, 24-week study.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Milnacipran treatment and pote ...... ve, open-label, 24-week study.
@en
Milnacipran treatment and pote ...... ve, open-label, 24-week study.
@nl
type
label
Milnacipran treatment and pote ...... ve, open-label, 24-week study.
@en
Milnacipran treatment and pote ...... ve, open-label, 24-week study.
@nl
prefLabel
Milnacipran treatment and pote ...... ve, open-label, 24-week study.
@en
Milnacipran treatment and pote ...... ve, open-label, 24-week study.
@nl
P2093
P2860
P356
P1476
Milnacipran treatment and pote ...... ive, open-label, 24-week study
@en
P2093
Daiji Sakurai
Hideki Komatsu
Hiroyuki Watanabe
Junpei Takahashi
Masaomi Iyo
Nobuhisa Kanahara
Tadashi Hasegawa
Takahiro Oiwa
Tasuku Hashimoto
Yasunori Oda
P2860
P304
P356
10.2147/NDT.S95067
P407
P577
2015-12-10T00:00:00Z